Discover strategies to overcome sample preparation challenges in clinical proteomics, optimizing workflows for researchers.
Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification of β-amyloid deposition. However, variability in quantitative measurements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results